Jury Deliberates Multibillion-Dollar Claim in Landmark Preterm Infant Formula Lawsuit Against Top Manufacturers

A jury in Wilmington, Delaware, is currently deliberating over a substantial lawsuit in which families are seeking over $6 billion from Abbott Laboratories and Reckitt Benckiser’s Mead Johnson. The lawsuit alleges that the companies failed to provide adequate warnings about the potential risks associated with consuming their cow’s milk-based infant formula for premature babies. The legal dispute centers around claims that ingesting these formulas can lead to a serious gastrointestinal disease known as necrotizing enterocolitis (NEC), which particularly affects preterm or otherwise medically vulnerable infants. NEC can cause severe intestinal damage and is potentially lethal. … Read more

Exploring Legal Strategies for GLP-1 Weight-Loss Drug Manufacturers in the U.S. Mass Tort Arena

New York — As the rates of obesity continue to climb at an alarming rate worldwide, pharmaceutical companies have intensified their efforts in advancing medications targeted at weight management. Among these, glucagon-like peptide-1 receptor (GLP-1) weight-loss drugs have been gaining attention not just for their efficacy but also for the litigation challenges they may face. Historically, the American mass tort litigation landscape offers extensive insights that are invaluable for these manufacturers in navigating potential legal battles. In the U.S., mass tort claims have frequently emerged in the pharmaceutical sector, with companies often finding themselves entangled … Read more

Thousands of Women Pursue Legal Action Against Paragard IUD Manufacturers Over Claims of Device Fracturing During Removal

In Atlanta, Georgia, a significant legal development unfolds as over 2,500 women have initiated lawsuits against Teva Pharmaceutical and CooperSurgical, the manufacturers of the Paragard intrauterine device (IUD). The litigants claim that the IUD, which is intended for long-term contraception, is prone to breaking during removal, leaving fragments inside the body. This has allegedly caused severe pain, additional medical procedures, and in some cases, lasting damage. The Paragard IUD, distinguished by its copper-based, non-hormonal design, is meant to provide up to 10 years of birth control. However, plaintiffs argue that the device’s rigid plastic arms … Read more

Heart Device Manufacturers Abiomed and Abbott Face Legal Challenges Over Impella and HeartMate Products

Boston, Massachusetts — In recent years, the medical device industry has seen significant advancements in technology designed to aid heart failure patients. However, not all innovations come without complications. Abiomed, a notable player in this field with its Impella heart pump, and Abbott Laboratories, known for its HeartMate product line, are currently facing legal challenges posed by users who allege complications from these devices. Heart pumps like Abiomed’s Impella and Abbott’s HeartMate series have been integral in supporting patients with severe heart conditions. These devices are designed to assist the heart in pumping blood throughout … Read more